• Webinars
  • Cardio-Metabolic and Renal Diseases, Neurological diseases, ALS
  • 26-11-2024

Webinar – Time to event trial designs in ALS: How useful are they?

On NOVEMBER 26th, 2024, we organised the webinar: Time to event trial designs in ALS: How useful are they? During this webinar, our speakers Ruben van Eijk, Lotte Smets, Jordi van Unnik and host Lieza Exalto explored the following topics: A...

Webinar: “RSV and Asthma”

On September 6, our partner ReSViNET presented the webinar: “RSV and Asthma” Prof Tina Hartert, MD, MPH shared her insights on RSV in relationship to asthma. Her study of almost two thousand children has identified that delay in early life ...

  • Webinars
  • Infectious Diseases & Vaccines, RSV, Vaccines

Webinar: Progress in RSV Vaccines and Monoclonal Antibodies

On May 10, our partner ReSViNET presented the webinar: Progress in RSV Vaccines and Monoclonal Antibodies In this webinar, Professor Barney Graham, MD, PhD, shared his views on the lanscape of RSV therapeutics. The webinar was hosted by Prof. D...

  • Webinars
  • Cardio-Metabolic and Renal Diseases, MASH (NASH)

Webinar: Lifestyle Interventions in NAFLD/NASH

On the 19th of September, we presented the 9th webinar of our NASH Webinar Series. During this webinar, speaker Professor Zelber-Sagi explored the relationship between diet and NAFLD, emphasizing that diet not only causes NAFLD but can also serve ...

Webinar: Real-World Data in ALS

On 30 May, we hosted the webinar "Real-World Data in ALS", in which we explored the innovative integration of Real World Data (RWD) in clinical trials for Amyotrophic Lateral Sclerosis (ALS). As a critical step forward in the pursuit of effective ...

Download

"*" indicates required fields

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Request for proposal

"*" indicates required fields

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
This field is for validation purposes and should be left unchanged.

Share

Twitter Facebook LinkedIn